GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk-Reference-Cited by-同舟云学术

GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk

Published:2017-11-17 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Pirastu Nicola^ORCID,Joshi Peter K.^ORCID,de Vries Paul S.,Cornelis Marilyn C.,McKeigue Paul M.,Keum NaNa,Franceschini Nora,Colombo Marco,Giovannucci Edward L.,Spiliopoulou Athina,Franke Lude^ORCID,North Kari E.,Kraft Peter,Morrison Alanna C.,Esko Tõnu^ORCID,Wilson James F.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-01490-8.pdf

Reference46 articles.

1. Trieu, N. & Eslick, G. D. Alopecia and its association with coronary heart disease and cardiovascular risk factors: a meta-analysis. Int. J. Cardiol. 176, 687–95 (2014).

2. Zhou, C. K. et al. Male pattern baldness in relation to prostate cancer-specific mortality: a prospective analysis in the NHANES I epidemiologic follow-up study. Am. J. Epidemiol. 183, 210–7 (2016).

3. Alfonso, M., Richter-Appelt, H., Tosti, A., Viera, M. S. & García, M. The psychosocial impact of hair loss among men: a multinational European study. Curr. Med. Res. Opin. 21, 1829–36 (2005).

4. Hillmer, A. M. et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am. J. Hum. Genet. 77, 140–148 (2005).

5. Prodi, D. A. et al. EDA2R is associated with androgenetic alopecia. J. Invest. Dermatol. 128, 2268–70 (2008).

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temperature-responsive detachable microneedles integrated with minoxidil nanoparticle for effectively promoting hair regrowth;Chemical Engineering Journal;2024-09

2. Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review;Cosmetics;2024-08-27

3. Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment;Bioactive Materials;2024-08

4. Multifunctional ionic liquids-mediated topical delivery of minoxidil and EGCG for treating androgenic alopecia through promoting angiogenesis and scavenging ROS;Chemical Engineering Journal;2024-07

5. Prioritizing susceptibility genes for the prognosis of male-pattern baldness with transcriptome-wide association study;Human Genomics;2024-04-02